BBP vs FINT
Comparison between VIRTUS BIOTECH ETF (BBP, ETF) and FRONTIER ASSET TOTAL INTERNATIONAL EQUITY ETF (FINT, ETF).
BBP vs FINT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
BBP
$78M
FINT
$78M
Expense Ratio
Winner
BBP
0.34%
FINT
0.87%
Max Drawdown
BBP
44.32%
Winner
FINT
13.64%
Sharpe Ratio
BBP
1.47
Winner
FINT
1.51
5Y Beta
BBP
0.86
Winner
FINT
0.72
P/E Ratio
BBP
-33.91
FINT
N/A
Forward P/E
BBP
13.79
FINT
N/A
5Y EPS CAGR
BBP
2.22%
FINT
N/A
Debt to Equity
BBP
36.59%
FINT
N/A
P/S Ratio
BBP
5.30
FINT
N/A
P/B Ratio
BBP
4.03
FINT
N/A
BBP vs FINT - Holdings Comparison
BBP and FINT have 0 common holdings. Overlap is 0.00%
BBP's top 25 holdings weight is 55.07%. FINT's top 25 holdings weight is 99.75%.
| Rank | BBP | FINT |
|---|---|---|
| #1 | IMMUNITYBIO INC ORDINARY SHARES (IBRX) - 5.10% | AVANTIS EMERGING MARKETS EQUITY ETF (AVEM) - 23.06% |
| #2 | IOVANCE BIOTHERAPEUTICS INC (IOVA) - 3.11% | ISHARES MSCI INTL QUALITY FACTOR ETF (IQLT) - 15.06% |
| #3 | LEGEND BIOTECH CORP ADR (LEGN) - 2.71% | ISHARES INTERNATIONAL EQUITY FACTOR ETF (INTF) - 14.85% |
| #4 | KALVISTA PHARMACEUTICALS INC (KALV) - 2.65% | ISHARES EM MKTS EQ FAC ETF (EMGF) - 11.54% |
| #5 | NOVAVAX INC (NVAX) - 2.59% | VANGUARD INTL DIV APPREC ETF (VIGI) - 9.94% |
| #6 | MODERNA INC (MRNA) - 2.58% | FIRST EAGLE OVERSEAS EQUITY ETF (FEOE) - 9.82% |
| #7 | AXSOME THERAPEUTICS INC (AXSM) - 2.50% | CAMBRIA FOREIGN SHAREHOLDER YIELD ETF (FYLD) - 8.62% |
| #8 | MIRUM PHARMACEUTICALS INC (MIRM) - 2.36% | FRANKLIN INTL LOW VOLATILITY HI DIV ETF (LVHI) - 6.86% |
| #9 | ROIVANT SCIENCES LTD ORDINARY SHARES (ROIV) - 2.13% | N/A |
| #10 | TRAVERE THERAPEUTICS INC ORDINARY SHARES (TVTX) - 2.06% | N/A |
| #11 | LIGAND PHARMACEUTICALS INC (LGND) - 2.05% | N/A |
| #12 | KRYSTAL BIOTECH INC (KRYS) - 2.00% | N/A |
| #13 | EXELIXIS INC (EXEL) - 1.98% | N/A |
| #14 | TG THERAPEUTICS INC (TGTX) - 1.95% | N/A |
| #15 | n/a (KNSA) - 1.88% | N/A |
| #16 | BIOCRYST PHARMACEUTICALS INC (BCRX) - 1.84% | N/A |
| #17 | UNITED THERAPEUTICS CORP (UTHR) - 1.82% | N/A |
| #18 | BIOGEN INC (BIIB) - 1.81% | N/A |
| #19 | HALOZYME THERAPEUTICS INC (HALO) - 1.78% | N/A |
| #20 | GILEAD SCIENCES INC (GILD) - 1.77% | N/A |
| #21 | AMGEN INC (AMGN) - 1.72% | N/A |
| #22 | NEUROCRINE BIOSCIENCES INC (NBIX) - 1.69% | N/A |
| #23 | ARROWHEAD PHARMACEUTICALS INC (ARWR) - 1.68% | N/A |
| #24 | BIOMARIN PHARMACEUTICAL INC (BMRN) - 1.67% | N/A |
| #25 | ASCENDIS PHARMA AS (ASND) - 1.64% | N/A |
| Total Holdings | 61 | 8 |
BBP vs FINT - Historical Returns
Returns include dividend reinvestment.
1M
BBP
-4.70%
Winner
FINT
-1.51%
3M
BBP
-1.59%
Winner
FINT
+6.24%
6M
BBP
+7.53%
Winner
FINT
+14.52%
1Y
Winner
BBP
+39.07%
FINT
+26.55%
5Y(CAGR)
BBP
+9.56%
FINT
N/A
10Y(CAGR)
BBP
+11.61%
FINT
N/A
Max(CAGR)
BBP
+10.90%
Winner
FINT
+28.76%
BBP vs FINT - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | BBP | FINT |
|---|---|---|
| 2026 | +5.54% | +10.83% |
| 2025 | +31.60% | +29.17% |
| 2024 | +1.76% | -0.15% |
| 2023 | +19.51% | N/A |
| 2022 | -0.92% | N/A |
| 2021 | -8.54% | N/A |
| 2020 | +23.26% | N/A |
| 2019 | +23.60% | N/A |
| 2018 | -15.04% | N/A |
| 2017 | +24.38% | N/A |
| 2016 | +10.01% | N/A |
| 2015 | +17.91% | N/A |
| 2014 | +0.27% | N/A |
BBP vs FINT Drawdown Comparison
The maximum drawdown for BBP was -44.32%, occurring on May 9, 2022. Recovery took 767 trading sessions.
The maximum drawdown for FINT was -13.64%, occurring on Apr 8, 2025. Recovery took 31 trading sessions.
The current BBP drawdown is -6.96%. The current FINT drawdown is -3.24%.
| Rank | BBP | FINT |
|---|---|---|
| #1 | -44.32% Feb 8, 2021 - Feb 27, 2024 | -13.64% Mar 19, 2025 - May 2, 2025 |
| #2 | -40.50% Jul 20, 2015 - Feb 9, 2017 | -10.08% Feb 25, 2026 - May 6, 2026 |
| #3 | -32.25% Jul 13, 2018 - May 11, 2020 | -4.24% Jun 2, 2026 - Jun 5, 2026 |
| #4 | -26.09% Nov 8, 2024 - Sep 2, 2025 | -4.13% Nov 12, 2025 - Dec 10, 2025 |
| #5 | -19.84% Feb 27, 2024 - Jul 15, 2024 | -3.94% Jul 23, 2025 - Aug 13, 2025 |
| #6 | -12.40% Jan 29, 2018 - Jun 19, 2018 | -3.60% Oct 6, 2025 - Oct 24, 2025 |
| #7 | -11.75% Jul 20, 2020 - Oct 7, 2020 | -3.59% Dec 23, 2024 - Jan 23, 2025 |
| #8 | -11.54% Apr 23, 2015 - Jun 5, 2015 | -2.49% May 11, 2026 - May 26, 2026 |
| #9 | -10.58% Jul 16, 2024 - Nov 6, 2024 | -2.36% Jun 12, 2025 - Jun 27, 2025 |
| #10 | -10.39% Oct 5, 2017 - Jan 22, 2018 | -2.34% Feb 20, 2025 - Mar 5, 2025 |
| #11 | -10.09% Jul 24, 2017 - Sep 29, 2017 | -2.19% Oct 27, 2025 - Nov 11, 2025 |
| #12 | -9.28% Feb 24, 2026 - Apr 14, 2026 | -2.08% Mar 7, 2025 - Mar 17, 2025 |
| #13 | -8.86% Mar 3, 2017 - Jun 20, 2017 | -1.91% Aug 22, 2025 - Sep 8, 2025 |
| #14 | -7.56% May 6, 2026 - Jun 2, 2026 | -1.82% Jan 30, 2025 - Feb 10, 2025 |
| #15 | -7.56% Jun 23, 2015 - Jul 14, 2015 | -1.62% Dec 11, 2025 - Dec 22, 2025 |
Correlation
Correlation between BBP and FINT is 0.93 which considered as a very strong positive correlation - the stocks move almost identically together.
0.93
-101
Dividend Comparison (2015 - 2025)
BBP vs FINT dividend yield comparison.
| Year | BBP | FINT |
|---|---|---|
| 2025 | 0.00% | 2.20% |
| 2017 | 0.18% | 0.00% |
| 2015 | 1.29% | 0.00% |
Select Stocks to Compare
Popular: BBP vs SPYFINT vs SPY
More Comparisons
Compare with similar stocks